Tue, May 27, 2025
Mon, May 26, 2025

[ Mon, May 26th 2025 ]: Forbes

Is Science Slowing Down?
Sun, May 25, 2025
Sat, May 24, 2025
Fri, May 23, 2025
Thu, May 22, 2025
Wed, May 21, 2025

[ Wed, May 21st 2025 ]: BBC

20 min meal: Brin's cumin beef
Tue, May 20, 2025

[ Tue, May 20th 2025 ]: 13abc

Moment of Science: Cicadas
Mon, May 19, 2025

When the FDA requires a large vaccine trial, who pays?

And more must-read biotech news brought to you by The Readout.
The article from STAT News dated May 20, 2025, discusses several key developments in the biotech industry. Pfizer has acquired Tourmaline Bio for $1.5 billion, aiming to bolster its immunology portfolio. Novavax is facing challenges with its Covid-19 vaccine, reporting a significant drop in sales and contemplating strategic alternatives. Prime Medicine has received FDA clearance for its first clinical trial using prime editing technology, marking a significant step in gene editing. Additionally, the FDA has approved a new CRISPR-based therapy for sickle cell disease, highlighting advancements in genetic treatments. The article also touches on the ongoing debate over vaccine mandates and the impact of recent court rulings on public health policies.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/05/20/biotech-news-pfizer-tourmaline-novavax-prime-crispr-fda-vaccines-the-readout/ ]